Health-care providers’ perspectives on uncertainty generated by variant forms of newborn screening targets
Open Access
- 10 October 2019
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (3), 566-573
- https://doi.org/10.1038/s41436-019-0670-3
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Achieving the “triple aim” for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence frameworkGenetics in Medicine, 2013
- Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort studyOrphanet Journal of Rare Diseases, 2012
- Congenital Diaphragmatic HerniaOrphanet Journal of Rare Diseases, 2012
- Mild hyperphenylalaninemia: to treat or not to treatJournal of Inherited Metabolic Disease, 2011
- Nationwide survey of extended newborn screening by tandem mass spectrometry in TaiwanJournal of Inherited Metabolic Disease, 2010
- When the Cystic Fibrosis Label Does Not Fit: A Modified Uncertainty TheoryQualitative Health Research, 2010
- Medicalization and MarketingJournal of Macromarketing, 2009
- A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiencyMolecular Genetics and Metabolism, 2009
- Is my sick child healthy? Is my healthy child sick?: Changing parental experiences of cystic fibrosis in the age of expanded newborn screeningSocial Science & Medicine (1982), 2008
- Uncertainty and Professional Work: Perceptions of Physicians in Clinical PracticeAmerican Journal of Sociology, 1992